SPTX · Seaport Therapeutics, Inc. · Fails to Deliver
$18.14
-0.18 (-0.96%)
At close · Nov 19
Return incl. dividend (before tax)
Market Cap
$980.14M
Shares
53.53M
Volume · Nov 19
63.59K
Avg daily vol (3M)
252.84K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-10-30 | 4 | $21.10 | $84 |
| 2026-10-29 | 37,505 | $20.38 | $764,352 |
| 2026-10-28 | 803 | $21.28 | $17,088 |
| 2026-10-27 | 13,693 | $20.83 | $285,225 |
| 2026-10-26 | 20,000 | $20.61 | $412,200 |
| 2026-10-22 | 619 | $19.73 | $12,213 |
| 2026-10-21 | 63,737 | $19.28 | $1,228,849 |
| 2026-10-20 | 72,060 | $17.79 | $1,281,947 |
| 2026-10-19 | 8,796 | $17.83 | $156,833 |
| 2026-10-15 | 11,363 | $16.68 | $189,535 |
| 2026-10-14 | 4,320 | $16.08 | $69,466 |
| 2026-10-08 | 16,249 | $17.93 | $291,345 |
| 2026-10-07 | 42 | $17.37 | $730 |
| 2026-10-06 | 151 | $18.50 | $2,794 |
| 2026-10-02 | 3,859 | $18.95 | $73,128 |
| 2026-10-01 | 3,164 | $20.17 | $63,818 |
| 2026-09-30 | 3 | $18.69 | $56 |
| 2026-09-29 | 4,310 | $19.64 | $84,648 |
| 2026-09-25 | 82 | $21.12 | $1,732 |
| 2026-09-24 | 12,260 | $21.29 | $261,015 |
| 2026-09-23 | 2,305 | $22.39 | $51,609 |
| 2026-09-22 | 2,426 | $21.12 | $51,237 |
| 2026-09-21 | 58,886 | $21.39 | $1,259,572 |
| 2026-09-18 | 1,986 | $21.82 | $43,335 |
| 2026-09-17 | 2,049 | $22.14 | $45,365 |
| 2026-09-16 | 4,041 | $22.96 | $92,781 |
| 2026-09-15 | 276 | $24.70 | $6,817 |
| 2026-09-11 | 2,429 | $23.28 | $56,547 |
| 2026-09-08 | 443 | $24.86 | $11,013 |
| 2026-09-03 | 791 | $24.91 | $19,704 |
| 2026-09-01 | 236 | $23.68 | $5,588 |
| 2026-08-28 | 600 | $26.25 | $15,750 |
| 2026-08-26 | 827 | $24.83 | $20,534 |
Showing 1–33 of 33 settlements
Key facts
CIK
2042347
CUSIP
81221K108
13F (30d)
73 filings
73 filers
Visit website
Investor relations